This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

Medicare Coverage Criteria for Oral and Intravenous Antiemetics

Medicare provides coverage for oral and intravenous (IV) antiemetics used in conjunction with chemotherapy. The details surrounding coverage differ between the two forms, and this article provides an overview of the criteria for each.

IV antiemetics that are administered in a physician's office under the "incident-to" rules are considered covered by Medicare. The incident-to rules have specific requirements that include the following:

• Physical presence of a physician. Because the service is being performed incident to a physician's service, a physician must be present in the office suite and must be immediately available to provide assistance while the service is being . . . [Click for More]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter